Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan Achieved Anti-Tumor Activity In Heavily Pretreated Patients

    Picture of Genmab A/S logoGenmab A/S
    18/10/2025 11:06
    Oct 18 (Reuters) - Genmab A/S GMAB.CO:

GENMAB ANNOUNCES NEW DATA DEMONSTRATING INVESTIGATIONAL RINATABART SESUTECAN (RINA-S®) ACHIEVED ANTI-TUMOR ACTIVITY IN HEAVILY PRETREATED PATIENTS WITH ADVANCED ENDOMETRIAL CANCER

Source text: ID:nBw5jHh6La

Further company coverage: GMAB.CO

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news